Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Elanco Animal Health Inc (ELAN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,391,648
  • Shares Outstanding, K 365,703
  • Annual Sales, $ 3,067 M
  • Annual Income, $ 86,500 K
  • 60-Month Beta N/A
  • Price/Sales 3.71
  • Price/Cash Flow 15.63
  • Price/Book 2.19

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.22
  • Number of Estimates 5
  • High Estimate 0.24
  • Low Estimate 0.20
  • Prior Year N/A
  • Growth Rate Est. (year over year) -99.98%

Price Performance

See More
Period Period Low Period High Performance
1-Month
30.75 +2.86%
on 04/18/19
33.47 -5.50%
on 04/05/19
-1.09 (-3.33%)
since 03/22/19
3-Month
28.00 +12.96%
on 02/06/19
33.47 -5.50%
on 04/05/19
+1.25 (+4.11%)
since 01/23/19

Most Recent Stories

More News
Investor Expectations to Drive Momentum within Dermira, Elanco Animal Health, Ready Capital, Cushman & Wakefield, BlueLinx, and Lydall -- Discovering Underlying Factors of Influence

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Dermira, Inc. (NASDAQ:DERM), Elanco...

RC : 14.85 (+0.47%)
DERM : 11.41 (+2.33%)
ELAN : 31.63 (+1.54%)
LDL : 25.85 (+2.62%)
CWK : 18.84 (+1.95%)
BXC : 24.31 (+0.16%)
MagnaChip and ELAN Microelectronics Announce Partnership to Expand OLED Display Capabilities for Next-Generation Applications

MagnaChip Semiconductor Corporation ("MagnaChip" or the "Company") (NYSE: MX), a designer and manufacturer of analog and mixed-signal semiconductor products, and ELAN Microelectronics Corp. (TWSE:ELAN),...

ELAN : 31.63 (+1.54%)
MX : 9.88 (+6.47%)
Accelerated Clinical Trials Bridging Gateway to Latest Treatments for Cancer Patients

Cancer research has for years been steadily gaining ground on its way to managing, curing and even preventing the various forms of this insidious disease. Both public and private money continues to flow...

ELAN : 31.63 (+1.54%)
AKBA : 6.67 (+1.83%)
PFE : 39.42 (+1.13%)
MBRX : 1.59 (-46.64%)
SEEL : 3.20 (+11.50%)
Lilly Announces Preliminary Results of Elanco Exchange Offer

Eli Lilly and Company (NYSE: LLY) today announced that, based on preliminary results, its previously-announced offer for shareholders to exchange their shares of Lilly common stock for shares of Elanco...

ELAN : 31.63 (+1.54%)
LLY : 117.49 (+1.75%)
Lilly Announces Final Exchange Ratio of 4.5121 for Elanco Exchange Offer

Eli Lilly and Company (NYSE: LLY) today announced the final exchange ratio for its previously-announced offer for shareholders to exchange their shares of Lilly common stock for shares of Elanco Animal...

ELAN : 31.63 (+1.54%)
LLY : 117.49 (+1.75%)
Do Options Traders Know Something About Elanco Health (ELAN) Stock We Don't?

Investors need to pay close attention to Elanco Health (ELAN) stock based on the movements in the options market lately.

ELAN : 31.63 (+1.54%)
Lilly to Begin Exchange Offer for Sale of Balance Elanco Stake

Eli Lilly (LLY) to initiate an exchange offer for shareholders to divest its remaining ownership interest in Elanco

ELAN : 31.63 (+1.54%)
LLY : 117.49 (+1.75%)
ZTS : 101.97 (+1.85%)
PFE : 39.42 (+1.13%)
Elanco Animal Health to File Registration Statement in Connection With Lilly Divestiture Announcement

Elanco Animal Health Incorporated (NYSE: ELAN), formerly the animal health business of Eli Lilly and Company (Lilly), today announced it intends to file a Form S-4 Registration Statement...

ELAN : 31.63 (+1.54%)
LLY : 117.49 (+1.75%)
Lilly Will Initiate Divestiture of its Remaining Interest in Elanco Animal Health

Eli Lilly and Company (NYSE: LLY) announced it will initiate an exchange offer today to divest its remaining interest in Elanco Animal Health (NYSE: ELAN).

ELAN : 31.63 (+1.54%)
LLY : 117.49 (+1.75%)
Eli Lilly (LLY) Q4 Earnings Coming Up: What's in the Cards?

Eli Lilly and Company's (LLY) new drugs like Trulicity, Taltz and Jardiance are performing well. Let's see if these along with its older products lead the company to an earnings beat.

ELAN : 31.63 (+1.54%)
NVO : 48.66 (+1.16%)
MRK : 74.60 (+1.55%)
LLY : 117.49 (+1.75%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Steady.

See More Share

Trade ELAN with:

Business Summary

Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States.

See More

Key Turning Points

2nd Resistance Point 32.12
1st Resistance Point 31.88
Last Price 31.63
1st Support Level 31.23
2nd Support Level 30.82

See More

52-Week High 37.61
Fibonacci 61.8% 33.94
Fibonacci 50% 32.81
Fibonacci 38.2% 31.67
Last Price 31.63
52-Week Low 28.00

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar